Export 1935 results:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Mowbray FI, Heckman G, Hirdes JP, Costa AP, Beauchet O, Archambault P, Eagles D, Wang HTing, Perry JJ, Sinha SK et al..  2023.  Agreement and prognostic accuracy of three ED vulnerability screeners: findings from a prospective multi-site cohort study. Canadian Journal of Emergency Medicine. 25(3):209-217.
Lix L.M, Yan L., Blackburn D., Hu N., Schneider-Lindner V., Shevchuk Y., Teare G.F.  2015.  Agreement between administrative data and the Resident Assessment Instrument Minimum Dataset (RAI-MDS) for medication use in long-term care facilities: a population-based study. BMC geriatrics. 15:24.
Steindal S.A, Sorbye L.W, Bredal I.S, Lerdal A..  2012.  Agreement in documentation of symptoms, clinical signs, and treatment at the end of life: a comparison of data retrieved from nurse interviews and electronic patient records using the Resident Assessment Instrument for Palliative Care. Journal of Clinical Nursing. 21(9-10):1416-24.
Little J, Hirdes JP, Daniel I.  2015.  ALC status in in-patient mental health settings:Evidence based on the Ontario Mental Health Reporting System. Healthcare Management Forum. 28(4):146-149.
Hsu AT, Manuel DG, Taljaard M, Chalifoux M, Bennett C, Costa AP, Bronskill S, Kobewka D, Tanuseputro P.  2016.  Algorithm for predicting death among older adults in the home care setting: study protocol for the Risk Evaluation for Support: Predictions for Elder-life in the Community Tool (RESPECT). BMJ Open. 6(12)
Warren R.L, Currie G.A.  1998.  American Subacute Care Association. Comparing OASIS, FIM, and MDS in assessing disability. Home Care Provid. 3(1):47-50.
Constanza L, Cruz C., Vacarezza A., Florenzano R., Trapp A..  2008.  Analisis comparativo de dos instrumentos de evaluacion clinica: OQ-45 e interRAI - Salud Mental (Comparative analysis between two instruments for clinical evaluation: OQ-45.2 and interRAI Mental Health). Rev Chil Neuro-Psiquiat. 46(3):192-198.
Buchanan R.J, Wang S., Huang C..  2001.  Analyses of nursing home residents with HIV and dementia using the minimum data set. J Acquir Immune Defic Syndr. 26(3):246-55.
Mentzel C, Glue P, Greco P, Barak Y.  2023.  Analysing Realistic effects of modifiable risk factors for dementia in a large National Dataset. Archives of Gerontology and Geriatrics. 105:104852.
Choi J.Y, Chun S., Kim H., Jung Y.I, Yoo S., Kim K.I.  2022.  Analysis of blood pressure and blood pressure variability pattern among older patients in long-term care hospitals: An observational study analysing the Health-RESPECT (integrated caRE Systems for elderly PatiEnts using iCT) dataset. Age and Ageing. 51(3)
Steel K., Vitale C., Whang P..  2000.  Annotated bibliography of palliative care and end of life care. J Am Geriatr Soc. 48(3):325-32.
Chatterjee S, Bali V, Carnahan RM, Chen H, Johnson ML, Aparasu RR.  2019.  Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression. Research in Social and Administrative Pharmacy.
Landi F., Dell'Aquila G., Collamati A., Martone A.M, Zuliani G., Gasperini B., Eusebi P., Lattanzio F., Cherubini A..  2014.  Anticholinergic Drug Use and Negative Outcomes Among the Frail Elderly Population Living in a Nursing Home. Journal of the American Medical Directors Association. 15(11):825-829.
Vetrano DL, La Carpia D, Grande G, Casucci P, Bacelli T, Bernabei R, Onder G, Agabiti N, Bartolini C, Bernabei R et al..  2016.  Anticholinergic Medication Burden and 5-Year Risk of Hospitalization and Death in Nursing Home Elderly Residents With Coronary Artery Disease. Journal of the American Medical Directors Association. 17(11):1056-1059.
McGregor A.L, Hoque M.R, Nickel S., Smith A.J, Atiquzzaman M..  2022.  Anti-Epileptic Medication Exposure Influences Functional Status in New Zealand Stroke Patients: A Retrospective Population-Level Study. Drugs - Real World Outcomes. 9(1):165-173.
Song W., Intrator O., Lee S., Boockvar K..  2018.  Antihypertensive Drug Deintensification and Recurrent Falls in Long-Term Care. Health Serv Res. 53(6):4066-4086.
Lapane K., Barbour MM, Van Haaren A, Gambassi G..  1999.  Antiischemic therapy in patients with coronary heart disease living in long-term care.. Pharmacotherapy. 19(5):627-634.
Liperoti R, Sganga F, Landi F, Topinkova E, Denkinger MD, van der Roest HG, Foebel AD, Finne-Soveri H, Bernabei R, Onder G.  2017.  Antipsychotic Drug Interactions and Mortality Among Nursing Home Residents With Cognitive Impairment. Journal of Clinical Psychiatry. 78(1):E76-E82.
Giani T., Villani E.R, Palmer K., Onder G., Liperoti R..  2022.  Antipsychotic use and risk of death in older adults with cognitive impairment: The role of frailty. European Geriatric Medicine. 13(Supplement 1):S277-S278.
Rios S, Perlman CM, Costa A, Heckman G, Hirdes JP, Mitchell L.  2017.  Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors. BMC Geriatr. 17(1):244.
Landi F., Onder G., Lattanzio F., Russo A., Barillaro C., Bernabei R., Bergamo SILVERNET-HCStudy Grou.  2003.  Antithrombotic drugs in secondary stroke prevention among a community dwelling older population. J Neurol Neurosurg Psychiatry. 74(8):1100-1104.
van Almenkerk S., Smalbrugge M., Depla M.FIA, Eefsting J.A, Hertogh C.MPM.  2015.  Apathy among institutionalized stroke patients: Prevalence and clinical correlates. American Journal of Geriatric Psychiatry. 23(2):180-188.
Volicer L., Frijters D.H, van der Steen J.T.  2013.  Apathy and weight loss in nursing home residents: longitudinal study. J Am Med Dir Assoc. 14(6):417-20.
Cruz C., Vacarezza A., Trapp A..  2007.  Aplicación del instrumento interRAI Salud Mental Comunitaria en centros ambulatorios de salud mental (Parte I). Revista de Administracion Sanitaria. XXIV:37-46.
Cruz C., Vacarezza A., Trapp A..  2007.  Aplicación del instrumento interRAI Salud Mental Comunitaria en centros ambulatorios de salud mental (Parte II). Revista de Administracion Sanitaria. XXIV:47-54.